Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - diclofenacum natríum - magasýruþolin tafla - 50 mg

Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - diclofenacum kalíum - filmuhúðuð tafla - 50 mg

Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

pfizer aps - fosphenytoinum dínatríum - stungulyf, lausn/innrennslisþykkni, lausn - 50 mg fe/ml

Unión Europea - islandés - EMA (European Medicines Agency)

extrovis eu ltd. - lacosamíð - flogaveiki - antiepileptics, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Unión Europea - islandés - EMA (European Medicines Agency)

merck sharp & dohme b.v. - bezlotoxumab - enterocolitis, pseudomembranous - Ónæmiskerfið sera og mótefni, - zinplava er ætlað til að koma í veg fyrir endurtekna clostridium difficile sýkingu (cdi) hjá fullorðnum sem eru í mikilli hættu á að endurtekna cdi.

Unión Europea - islandés - EMA (European Medicines Agency)

a. menarini industrie farmaceutiche riunite s.r.l. - delafloxacin meglúmíni - samfarir í bandalaginu - sýklalyf fyrir almenn nota, - quofenix is indicated for the treatment of the following infections in adults:acute bacterial skin and skin structure infections (absssi),community-acquired pneumonia (cap), when it is considered inappropriate to use other antibacterial agents that are commonly recommended for the initial treatment of these infections (see sections 4. 4 og 5. Íhuga ætti að opinbera leiðsögn á réttri notkun af sýklalyfjum.

Unión Europea - islandés - EMA (European Medicines Agency)

shionogi b.v. - cefiderocol súlfat tosilate - gramm-neikvæð bakteríusýkingum - sýklalyf fyrir almenn nota, - fetcroja er ætlað fyrir meðferð sýkingum vegna úti gramm-neikvæð lífvera í fullorðnir með takmarkaða meðferð valkosti (sjá kafla 4. 2, 4. 4 og 5. Íhuga ætti að opinbera leiðsögn á réttri notkun af sýklalyfjum.

Unión Europea - islandés - EMA (European Medicines Agency)

accord healthcare s.l.u. - lacosamíð - flogaveiki - antiepileptics, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy•         in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. •         in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.

Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

eql pharma ab - clindamycinum hýdróklóríð - hart hylki - 150 mg

Islandia - islandés - LYFJASTOFNUN (Icelandic Medicines Agency)

eql pharma ab - clindamycinum hýdróklóríð - hart hylki - 300 mg